L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

L01 ANTINEOPLASTIC AGENTS

L01A ALKYLATING AGENTS

L01AA Nitrogen mustard analogues
L01AA01 - cyclophosphamide (Wiki, WHO)
L01AA02 - chlorambucil (Wiki, WHO)
L01AA03 - melphalan (Wiki, WHO)
L01AA05 - chlormethine (Wiki, WHO)
L01AA06 - ifosfamide (Wiki, WHO)
L01AA09 - bendamustine (Wiki, WHO)

L01AB Alkyl sulfonates
L01AB01 - busulfan (Wiki, WHO)
L01AB02 - treosulfan (Wiki, WHO)

L01AC Ethylene imines
L01AC01 - thiotepa (Wiki, WHO)

L01AD Nitrosoureas
L01AD01 - carmustine (Wiki, WHO)
L01AD02 - lomustine (Wiki, WHO)

L01AX Other alkylating agents
L01AX03 - temozolomide (Wiki, WHO)
L01AX04 - dacarbazine (Wiki, WHO)

L01B ANTIMETABOLITES

L01BA Folic acid analogues
L01BA01 - methotrexate (Wiki, WHO)
L01BA03 - raltitrexed (Wiki, WHO)
L01BA04 - pemetrexed (Wiki, WHO)
L01BA05 - pralatrexate% (Wiki, WHO)

L01BB Purine analogues
L01BB02 - mercaptopurine (Wiki, WHO)
L01BB03 - tioguanine (Wiki, WHO)
L01BB04 - cladribine (Wiki, WHO)
L01BB05 - fludarabine (Wiki, WHO)
L01BB06 - clofarabine (Wiki, WHO)
L01BB07 - nelarabine (Wiki, WHO)

L01BC Pyrimidine analogues
L01BC01 - cytarabine (Wiki, WHO)
L01BC02 - fluorouracil (Wiki, WHO)
L01BC05 - gemcitabine (Wiki, WHO)
L01BC06 - capecitabine (Wiki, WHO)
L01BC07 - azacitidine (Wiki, WHO)
L01BC08 - decitabine (Wiki, WHO)
L01BC52 - fluorouracil, combinations (Wiki, WHO)
L01BC58 - decitabine, combinations (Wiki, WHO)
L01BC59 - trifluridine, combinations (Wiki, WHO)

L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS

L01CA Vinca alkaloids and analogues
L01CA01 - vinblastine (Wiki, WHO)
L01CA02 - vincristine (Wiki, WHO)
L01CA04 - vinorelbine (Wiki, WHO)

L01CB Podophyllotoxin derivatives
L01CB01 - etoposide (Wiki, WHO)

L01CD Taxanes
L01CD01 - paclitaxel (Wiki, WHO)
L01CD02 - docetaxel (Wiki, WHO)
L01CD04 - cabazitaxel (Wiki, WHO)

L01CX Other plant alkaloids and natural products
L01CX01 - trabectedin (Wiki, WHO)

L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

L01DA Actinomycines
L01DA01 - dactinomycin (Wiki, WHO)

L01DB Anthracyclines and related substances
L01DB01 - doxorubicin (Wiki, WHO)
L01DB02 - daunorubicin (Wiki, WHO)
L01DB03 - epirubicin (Wiki, WHO)
L01DB06 - idarubicin (Wiki, WHO)
L01DB07 - mitoxantrone (Wiki, WHO)

L01DC Other cytotoxic antibiotics
L01DC01 - bleomycin (Wiki, WHO)
L01DC03 - mitomycin (Wiki, WHO)

L01X OTHER ANTINEOPLASTIC AGENTS

L01XA Platinum compounds
L01XA01 - cisplatin (Wiki, WHO)
L01XA02 - carboplatin (Wiki, WHO)
L01XA03 - oxaliplatin (Wiki, WHO)

L01XB Methylhydrazines
L01XB01 - procarbazine (Wiki, WHO)

L01XD Sensitizers used in photodynamic/radiation therapy
L01XD03 - methyl aminolevulinate (Wiki, WHO)
L01XD04 - aminolevulinic acid (Wiki, WHO)

L01XX Other antineoplastic agents
L01XX02 - asparaginase (Wiki, WHO)
L01XX05 - hydroxycarbamide (Wiki, WHO)
L01XX23 - mitotane (Wiki, WHO)
L01XX24 - pegaspargase (Wiki, WHO)
L01XX27 - arsenic trioxide (Wiki, WHO)
L01XX35 - anagrelide (Wiki, WHO)
L01XX41 - eribulin (Wiki, WHO)
L01XX52 - venetoclax (Wiki, WHO)
L01XX66 - selinexor (Wiki, WHO)
L01XX69 - lurbinectedin (Wiki, WHO)
L01XX73 - sotorasib (Wiki, WHO)
L01XX74 - belzutifan (Wiki, WHO)
L01XX75 - tebentafusp (Wiki, WHO)

L01XY Combinations of antineoplastic agents
L01XY01 - cytarabine and daunorubicin (Wiki, WHO)

L02 ENDOCRINE THERAPY

L02A HORMONES AND RELATED AGENTS

L02AB Progestogens
L02AB01 - megestrol (Wiki, WHO)

L02AE Gonadotropin releasing hormone analogues
L02AE01 - buserelin (Wiki, WHO)
L02AE02 - leuprorelin (Wiki, WHO)
L02AE03 - goserelin (Wiki, WHO)
L02AE04 - triptorelin (Wiki, WHO)

L02B HORMONE ANTAGONISTS AND RELATED AGENTS

L02BA Anti-estrogens
L02BA01 - tamoxifen (Wiki, WHO)
L02BA03 - fulvestrant (Wiki, WHO)

L02BB Anti-androgens
L02BB01 - flutamide (Wiki, WHO)
L02BB02 - nilutamide (Wiki, WHO)
L02BB03 - bicalutamide (Wiki, WHO)
L02BB04 - enzalutamide (Wiki, WHO)
L02BB05 - apalutamide (Wiki, WHO)
L02BB06 - darolutamide (Wiki, WHO)

L02BG Enzyme inhibitors
L02BG03 - anastrozole (Wiki, WHO)
L02BG04 - letrozole (Wiki, WHO)
L02BG06 - exemestane (Wiki, WHO)

L02BX Other hormone antagonists and related agents
L02BX02 - degarelix (Wiki, WHO)
L02BX03 - abiraterone (Wiki, WHO)
L02BX04 - relugolix (Wiki, WHO)

L03 IMMUNOSTIMULANTS

L03A IMMUNOSTIMULANTS

L03AA Colony stimulating factors
L03AA02 - filgrastim (Wiki, WHO)
L03AA13 - pegfilgrastim (Wiki, WHO)

L03AB Interferons
L03AB07 - interferon beta-1a (Wiki, WHO)
L03AB08 - interferon beta-1b (Wiki, WHO)
L03AB11 - peginterferon alfa-2a (Wiki, WHO)
L03AB13 - peginterferon beta-1a (Wiki, WHO)

L03AC Interleukins
L03AC01 - aldesleukin (Wiki, WHO)

L03AX Other immunostimulants
L03AX03 - bcg vaccine (Wiki, WHO)
L03AX13 - glatiramer acetate (Wiki, WHO)
L03AX16 - plerixafor (Wiki, WHO)

L04 IMMUNOSUPPRESSANTS

L04A IMMUNOSUPPRESSANTS

L04AA Selective immunosuppressants
L04AA03 - antilymphocyte immunoglobulin (horse) (Wiki, WHO)
L04AA04 - antithymocyte immunoglobulin (rabbit) (Wiki, WHO)
L04AA06 - mycophenolic acid (Wiki, WHO)
L04AA24 - abatacept (Wiki, WHO)
L04AA32 - apremilast (Wiki, WHO)
L04AA40* - cladribine (Wiki, WHO)
L04AA48 - belumosudil (Wiki, WHO)
L04AA58 - efgartigimod alfa (Wiki, WHO)

L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB01 - etanercept (Wiki, WHO)
L04AB02 - infliximab (Wiki, WHO)
L04AB04 - adalimumab (Wiki, WHO)
L04AB05 - certolizumab pegol (Wiki, WHO)
L04AB06 - golimumab (Wiki, WHO)

L04AC Interleukin inhibitors
L04AC02 - basiliximab (Wiki, WHO)
L04AC03 - anakinra (Wiki, WHO)
L04AC05 - ustekinumab (Wiki, WHO)
L04AC07 - tocilizumab (Wiki, WHO)
L04AC08 - canakinumab (Wiki, WHO)
L04AC10 - secukinumab (Wiki, WHO)
L04AC11 - siltuximab (Wiki, WHO)
L04AC12 - brodalumab (Wiki, WHO)
L04AC13 - ixekizumab (Wiki, WHO)
L04AC14 - sarilumab (Wiki, WHO)
L04AC16 - guselkumab (Wiki, WHO)
L04AC17 - tildrakizumab (Wiki, WHO)
L04AC18 - rizankizumab (Wiki, WHO)
L04AC19 - satralizumab (Wiki, WHO)
L04AC21 - bimekizumab (Wiki, WHO)
L04AC22 - spesolimab (Wiki, WHO)
L04AC24 - mirikizumab (Wiki, WHO)

L04AD Calcineurin inhibitors
L04AD01 - ciclosporin (Wiki, WHO)
L04AD02 - tacrolimus (Wiki, WHO)

L04AX Other immunosuppressants
L04AX01 - azathioprine (Wiki, WHO)
L04AX02 - thalidomide (Wiki, WHO)
L04AX03 - methotrexate (Wiki, WHO)
L04AX04 - lenalidomide (Wiki, WHO)
L04AX05 - pirfenidone (Wiki, WHO)
L04AX06 - pomalidomide (Wiki, WHO)
L04AX07 - dimethyl fumarate (Wiki, WHO)